Related references
Note: Only part of the references are listed.Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
Carl Arne Lochen Arnesen et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2022)
Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI
Alok A. Khorana et al.
BLOOD ADVANCES (2022)
Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism
Tobias Frischmuth et al.
THROMBOSIS AND HAEMOSTASIS (2022)
Impact of hereditary thrombophilia on cancer-associated thrombosis, tumour susceptibility and progression: A review of existing evidence
Valeria Tavares et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2022)
Venous thromboembolism in cancer and cancer immunotherapy
Salah Eddine Ousama Kacimi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
Immunotherapy-related skeletal muscle weakness in cancer patients: a case series
Amy H. Ng et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Epidemiology of Cancer-Associated Thrombosis in Asia: A Systematic Review
Lai Heng Lee et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice
Malinda T. West et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Venous thromboembolism in cancer patients: a population-based cohort study
F. Mulder et al.
BLOOD (2021)
Pancreatic cancer induces muscle wasting by promoting the release of pancreatic adenocarcinoma upregulated factor
Wonbeak Yoo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Interplay between inflammation and thrombosis in cardiovascular pathology
Konstantin Stark et al.
NATURE REVIEWS CARDIOLOGY (2021)
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles
Nadim Tawil et al.
BLOOD ADVANCES (2021)
Overall survival with warfarin vs. low-molecular-weight heparin in cancer-associated thrombosis
Thita Chiasakul et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
The Spectrum of Malnutrition/Cachexia/Sarcopenia in Oncology According to Different Cancer Types and Settings: A Narrative Review
Paolo Bossi et al.
NUTRIENTS (2021)
The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
Michalis Karamouzis et al.
CANCERS (2021)
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines
J. Arends et al.
ESMO OPEN (2021)
Increased incidence of venous thromboembolism with cancer immunotherapy
Joanna Roopkumar et al.
MED (2021)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cancer cachexia: a multifactoral disease that needs a multimodal approach
Renee Stubbins et al.
CURRENT OPINION IN GASTROENTEROLOGY (2020)
Potential Mechanisms of Cancer-Related Hypercoagulability
Nicola J. Nasser et al.
CANCERS (2020)
Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options
Gioacchino P. Marceca et al.
FRONTIERS IN ONCOLOGY (2020)
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
Sara Peixoto da Silva et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Biological Sex Mediates Cancer Cachexia Associated Muscle Weakness
George Blackburn et al.
FASEB JOURNAL (2020)
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Tobias Herold et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Management of Cancer Cachexia: ASCO Guideline
Eric J. Roeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Pancreatic Cancer and Cachexia-Metabolic Mechanisms and Novel Insights
Kalliopi Anna Poulia et al.
NUTRIENTS (2020)
Cancer Cachexia Induces Preferential Skeletal Muscle Myosin Loss When Combined With Denervation
Takashi Yamada et al.
FRONTIERS IN PHYSIOLOGY (2020)
Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis
Gary H. Lyman et al.
THROMBOSIS RESEARCH (2020)
Hormones and thrombosis: risk across the reproductive years and beyond
Nicoletta Machin et al.
TRANSLATIONAL RESEARCH (2020)
Understanding and Overcoming the Inflammatory Toxicities of Immunotherapy
Michael Dougan
CANCER IMMUNOLOGY RESEARCH (2020)
Sex Differences in Cancer Cachexia
Xiaoling Zhong et al.
CURRENT OSTEOPOROSIS REPORTS (2020)
Abnormal Metaphase Cytogenetics Adds to Currently Known Risk-Factors for Venous Thromboembolism in Multiple Myeloma: Derivation of the PRISM score
Rajshekhar Chakraborty et al.
BLOOD (2020)
Association Between Familial Mediterranean Fever and Cachexia in Females
Yunus Durmaz et al.
ARCHIVES OF RHEUMATOLOGY (2020)
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors
Sudan N. Loganathan et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Development and characterization of a cancer cachexia model employing a rare human duodenal neuroendocrine carcinoma-originating cell line
Kazuyoshi Yanagihara et al.
Oncotarget (2019)
Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism
Fabrizio Pin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Endogenous sex hormones and risk of venous thromboembolism in young women
Luuk J. J. Scheres et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
The clinical relevance of adiposity when assessing muscle health in men treated with androgen deprivation for prostate cancer
Patrick J. Owen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers
Laetitia Koppe et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities
Jennifer B. Permuth et al.
CANCER MEDICINE (2019)
The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues
Elena Campello et al.
BRITISH JOURNAL OF CANCER (2019)
Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma
Ang Li et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa
Raquel G. F. Costa et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
A Narrative Review of Cancer-Related Fatigue (CRF) and Its Possible Pathogenesis
Songwei Yang et al.
CELLS (2019)
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
Kristen M. Sanfilippo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases
Jens J. Posma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Frits I. Mulder et al.
HAEMATOLOGICA (2019)
PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway
Liang Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Measuring cachexia-diagnostic criteria
Rony Dev
ANNALS OF PALLIATIVE MEDICINE (2019)
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Marion Mussbacher et al.
FRONTIERS IN IMMUNOLOGY (2019)
It's more than low BMI: prevalence of cachexia and associated mortality in COPD
Merry-Lynn N. McDonald et al.
RESPIRATORY RESEARCH (2019)
Cancer-associated thrombosis: the when, how and why
Caio J. Fernandes et al.
EUROPEAN RESPIRATORY REVIEW (2019)
Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia
Ashok Narasimhan et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis
Steven P. Grover et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Frequency, risk actors, and impact on mortality of arterial thromboembolism in patients with cancer
Ella Grilz et al.
HAEMATOLOGICA (2018)
PULMONARY EMBOLISM AMONG PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: IMPLICATIONS FOR EMERGENCY MEDICINE
Ali Pourmand et al.
JOURNAL OF EMERGENCY MEDICINE (2018)
Platinum-induced muscle wasting in cancer chemotherapy: Mechanisms and potential targets for therapeutic intervention
Alexandra Moreira-Pais et al.
LIFE SCIENCES (2018)
Updated clinical models for VTE prediction in hospitalized medical patients
Grigoris T. Gerotziafas et al.
THROMBOSIS RESEARCH (2018)
What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients' Quality of Life?
Andrew J. Lloyd et al.
VALUE IN HEALTH (2018)
Frequency, risk actors, and impact on mortality of arterial thromboembolism in patients with cancer
Ella Grilz et al.
HAEMATOLOGICA (2018)
Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naive pancreatic cancer patients
Erin E. Talbert et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Cancer-associated cachexia
Vickie E. Baracos et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer
Steven K. M. Lau et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Cancer cachexia and myopenia - Update on management strategies and the direction of future research for optimizing body composition in cancer - A narrative review
Edward T. Pring et al.
CANCER TREATMENT REVIEWS (2018)
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX)
Antonio Girolami et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism
Wendy Lim et al.
BLOOD ADVANCES (2018)
Psychosocial Support in Cancer Cachexia Syndrome: The Evidence for Supported Self-Management of Eating Problems during Radiotherapy or Chemotherapy Treatment
Jane Hopkinson
ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING (2018)
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss
Neil Johns et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
Nick van Es et al.
HAEMATOLOGICA (2017)
Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score
L. Bertoletti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH
A. Delluc et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent
C. J. Reddel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
TNF-α and cancer cachexia: Molecular insights and clinical implications
Hetal J. Patel et al.
LIFE SCIENCES (2017)
Cancer Cachexia: Cause, Diagnosis, and Treatment
Todd W. Mattox
NUTRITION IN CLINICAL PRACTICE (2017)
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study
Chiara Alessandra Cella et al.
ONCOLOGIST (2017)
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study
Grigoris T. Gerotziafas et al.
ONCOLOGIST (2017)
Cancer and Venous Thromboembolic Disease: A Review
Eoin Donnellan et al.
ONCOLOGIST (2017)
Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer
Anne W. Wendrich et al.
ORAL ONCOLOGY (2017)
Venous thromboembolism: Past, present and future
Sam Schulman et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Cancer-associated venous thromboembolism: Burden, mechanisms, and management
Cihan Ay et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer A population-based cohort study
Alexander T. Cohen et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
Nick van Es et al.
HAEMATOLOGICA (2017)
Supportive care in pancreatic ductal adenocarcinoma
B. Laquente et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
ESPEN expert group recommendations for action against cancer-related malnutrition
J. Arends et al.
CLINICAL NUTRITION (2017)
Mechanisms and risk factors of thrombosis in cancer
Anna Falange et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Cancer-associated pathways and biomarkers of venous thrombosis
Yohei Hisada et al.
BLOOD (2017)
Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism A Systematic Review and Meta-analysis of Individual Patient Data
Nick van Es et al.
ANNALS OF INTERNAL MEDICINE (2017)
ESPEN guidelines on definitions and terminology of clinical nutrition
T. Cederholm et al.
CLINICAL NUTRITION (2017)
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
F. Roila et al.
ANNALS OF ONCOLOGY (2016)
Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia
Claudia A. Penafuerte et al.
BRITISH JOURNAL OF CANCER (2016)
Cross Talk Pathways Between Coagulation and Inflammation
Jonathan H. Foley et al.
CIRCULATION RESEARCH (2016)
Mechanisms of metabolic dysfunction in cancer-associated cachexia
Michele Petruzzelli et al.
GENES & DEVELOPMENT (2016)
Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism
Olga V. Gran et al.
HAEMATOLOGICA (2016)
The epidemiology of venous thromboembolism
John A. Heit et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Hypothalamic inflammation and food intake regulation during chronic illness
J. T. Dwarkasing et al.
PEPTIDES (2016)
Environmental and Genetic Risk Factors Associated with Venous Thromboembolism
Marta Crous-Bou et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2016)
Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism
Olga V. Gran et al.
HAEMATOLOGICA (2016)
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)
Andrew J. Stewart Coats et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer
David Witte et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Fibrinolysis and the control of blood coagulation
John C. Chapin et al.
BLOOD REVIEWS (2015)
Pathophysiology of anorexia in the cancer cachexia syndrome
Chukwuemeka Charles Ezeoke et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy
Mojca Gorenc et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2015)
Can Megestrol Acetate Induce Thrombosis in Advanced Oncology Patients Receiving Chemotherapy?
Cetin Ordu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Mechanisms Linking Leptin to Arterial and Venous Thrombosis: Potential Pharmacological Targets
Katrin Schaefer et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Sarcopenia, Cachexia and Aging: Diagnosis, Mechanisms and Therapeutic Options - A Mini-Review
Sumbul Ali et al.
GERONTOLOGY (2014)
Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment
R. E. J. Roach et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Cancer-associated unsuspected pulmonary embolism
Nick van Es et al.
THROMBOSIS RESEARCH (2014)
Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
Claudio Pietra et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)
Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014
Stephan von Haehling et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)
Epidemiology of cancer-associated venous thrombosis
Jasmijn F. Timp et al.
BLOOD (2013)
Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States
Alok A. Khorana et al.
CANCER (2013)
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
Wei A. He et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
Adrian S. Dobs et al.
LANCET ONCOLOGY (2013)
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Leptin signaling and leptin resistance
Yingjiang Zhou et al.
FRONTIERS OF MEDICINE (2013)
Iron-saturated bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice
Xueying Sun et al.
BMC CANCER (2012)
P-selectin genotype is associated with the development of cancer cachexia
Benjamin H. L. Tan et al.
EMBO MOLECULAR MEDICINE (2012)
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
Melina Verso et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis
Sonia Seng et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review
Benjamin H. L. Tan et al.
JOURNAL OF GENETICS (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Prediction of venous thromboembolism in cancer patients
Cihan Ay et al.
BLOOD (2010)
The risk of cancer in patients with venous thromboembolism does not exceed that expected in the general population after the first 6 months
P. Prandoni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms
Keattiyoat Wattanakit et al.
CURRENT OPINION IN PULMONARY MEDICINE (2009)
Venous Thromboembolism in the Hematologic Malignancies
Anna Falanga et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Satish L. Deshmane et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Systematic review: The trousseau syndrome revisited: Should we screen extensively for cancer in patients with venous thromboembolism?
Marc Carrier et al.
ANNALS OF INTERNAL MEDICINE (2008)
Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (II, VII, IX and X)
N. N. Negrev et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2008)
Trousseau's syndrome: Multiple definitions and multiple mechanisms
Ajit Varki
BLOOD (2007)
Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk?
E. Napoleone et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
The lethal phenotype of cancer: The molecular basis of death due to malignancy
Robert D. Loberg et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer
Alok A. Khorana et al.
CLINICAL CANCER RESEARCH (2007)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring
JY Chen et al.
ENDOCRINOLOGY (2005)
The relationship between inflammation and venous thrombosis - A systematic review of clinical studies
EA Fox et al.
THROMBOSIS AND HAEMOSTASIS (2005)
The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma - A systematic review
SR Deitcher et al.
CANCER (2004)
The prothrombotic state in cancer: pathogenic mechanisms
M De Cicco
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma
JW Blom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas
M Wahrenbrock et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Malignancy, thrombosis and Trousseau: the case for an eponym
AA Khorana
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Pulmonary cachexia
AMWJ Schols
INTERNATIONAL JOURNAL OF CARDIOLOGY (2002)
Pathogenesis of thrombosis in patients with malignancy
A Falanga et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)
Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study
JA Heit et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
